Chromadex Corp Stock
Chromadex Corp Stock
A loss of -1.120% shows a downward development for Chromadex Corp.
We see a rather positive sentiment for Chromadex Corp with 10 Buy predictions and 2 Sell predictions.
With a target price of 5 € there is a positive potential of 42.05% for Chromadex Corp compared to the current price of 3.52 €.
Our community identified positive and negative aspects for Chromadex Corp stock for the coming years. 0 users see the criterium "EBIT Margin" as a plus for the Chromadex Corp stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Chromadex Corp in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chromadex Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chromadex Corp | -1.120% | 10.559% | -8.247% | 187.097% | 165.672% | -42.581% | - |
| Organovo Holdings Inc. | -6.110% | -11.423% | -7.338% | -49.773% | -13.840% | -85.626% | -95.105% |
| Intellia Therapeutics Inc | 5.180% | 6.833% | -8.148% | -45.455% | -26.010% | -61.558% | 44.779% |
| VBI Vaccines Inc. | 0.540% | 5.962% | -14.706% | -77.871% | 3.962% | -99.164% | -98.942% |
Comments
ChromaDex Co. (NASDAQ: CDXC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) had its price target raised by analysts at Roth Mkm from $4.25 to $6.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat